Pulse 2014 ONC Certified, Complete EHR-EMR

The Pulse Complete EHR-EMR is one of the most robust and versatile electronic health record systems on the market today. It offers unparalleled workflow and documentation flexibility for providers. Each provider in a practice can customize Pulse to meet their personal workflow, thereby increasing productivity and efficiency. The Pulse Complete EHR offers additional customization with specialty-specific features and templates, all of which can be integrated seamlessly and easily.

For those practices unsatisfied with their current EHR, Pulse offers advanced clinical data conversion services. We excel at converting both clinical and non-clinical data from other EHR vendors, making the transition to Pulse refreshingly painless.

Physicians in more than 40 specialties – and from both large and small practices – have placed their trust in the Pulse Complete EHR. We hope that you find our award-winning products and support the perfect fit for your practice.

This Pulse Complete EHR, version 5.0.14, is compliant with the ONC 2014 Edition criteria and has been certified by an ONC-ACB on December 22, 2015. In accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services
ONC Certification HIT 2014 Complete EHR

Pulse Complete EHR 5.0.14 CHPL ID: 150141R00  |  Certified: 12.22.2015

Certification Criteria

  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS56: Functional Status Assessment for Hip Replacement
CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed
CMS62: HIV/AIDS: Medical Visit
CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement>
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75: Children Who Have Dental Decay or Cavities
CMS77: HIV/AIDS: RNA control for Patients with HIV
CMS82: Maternal Depression Screening
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS117: Childhood Immunization Status
CMS122: Diabetes: Hemoglobin A1c Poor Control
CMS123: Diabetes: Foot Exam
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS126: Use of Appropriate Medications for Asthma
CMS127: Pneumonia Vaccination Status for Older Adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130: Colorectal Cancer Screening
CMS131: Diabetes: Eye Exam
CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134: Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer
CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients
CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS148: Hemoglobin A1c Test for Pediatric Patients
CMS149: Dementia: Cognitive Assessment
CMS153: Chlamydia Screening for Women
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156: Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS158: Pregnant women that had HBsAg testing
CMS159: Depression Remission at Twelve Months
CMS160: Depression Utilization of the PHQ-9 Tool
CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS163: Diabetes: Low Density Lipoprotein (LDL) Management
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain
CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range
CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control>

Pulse Complete EHR 5.0.01 CHPL ID: 140276R01  |  Certified: 05.13.2015

Certification Criteria

  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(d)(9) – Optional – accounting of disclosures
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS56: Functional Status Assessment for Hip Replacement
CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed
CMS62: HIV/AIDS: Medical Visit
CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement>
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75: Children Who Have Dental Decay or Cavities
CMS77: HIV/AIDS: RNA control for Patients with HIV
CMS82: Maternal Depression Screening
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS117: Childhood Immunization Status
CMS122: Diabetes: Hemoglobin A1c Poor Control
CMS123: Diabetes: Foot Exam
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS126: Use of Appropriate Medications for Asthma
CMS127: Pneumonia Vaccination Status for Older Adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130: Colorectal Cancer Screening
CMS131: Diabetes: Eye Exam
CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134: Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer
CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients
CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS148: Hemoglobin A1c Test for Pediatric Patients
CMS149: Dementia: Cognitive Assessment
CMS153: Chlamydia Screening for Women
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156: Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS158: Pregnant women that had HBsAg testing
CMS159: Depression Remission at Twelve Months
CMS160: Depression Utilization of the PHQ-9 Tool
CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS163: Diabetes: Low Density Lipoprotein (LDL) Management
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain
CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range
CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control

Pulse Complete EHR 5.0 CHPL ID: 140276R00  |  Certified: 10.02.2014

Certification Criteria

  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(d)(9) – Optional – accounting of disclosures
  • 170.314(e)(2) – Ambulatory setting only – clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS56: Functional Status Assessment for Hip Replacement
CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed
CMS62: HIV/AIDS: Medical Visit
CMS64: Preventive Care and Screening: Risk-Stratified Cholesterol -Fasting Low Density Lipoprotein (LDLC)
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement>
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75: Children Who Have Dental Decay or Cavities
CMS77: HIV/AIDS: RNA control for Patients with HIV
CMS82: Maternal Depression Screening
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS117: Childhood Immunization Status
CMS122: Diabetes: Hemoglobin A1c Poor Control
CMS123: Diabetes: Foot Exam
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS126: Use of Appropriate Medications for Asthma
CMS127: Pneumonia Vaccination Status for Older Adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130: Colorectal Cancer Screening
CMS131: Diabetes: Eye Exam
CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134: Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS136: ADHD: Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivi ty Disorder (ADHD) Medication
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS140: Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/ Progesterone Receptor (ER/PR) Positive Breast Cancer
CMS141: Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients
CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS148: Hemoglobin A1c Test for Pediatric Patients
CMS149: Dementia: Cognitive Assessment
CMS153: Chlamydia Screening for Women
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156: Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS158: Pregnant women that had HBsAg testing
CMS159: Depression Remission at Twelve Months
CMS160: Depression Utilization of the PHQ-9 Tool
CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS163: Diabetes: Low Density Lipoprotein (LDL) Management
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain
CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS179: ADE Prevention and Monitoring: Warfarin Time in Therapeutic Range
CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control>

Pulse Complete EHR 4.2.08 CHPL ID: 140191R00  |  Certified: 07.23.2014

Certification Criteria

  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS52: HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis
CMS56: Functional Status Assessment for Hip Replacement
CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed
CMS62: HIV/AIDS: Medical Visit
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement>
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS75: Children Who Have Dental Decay or Cavities
CMS77: HIV/AIDS: RNA control for Patients with HIV
CMS82: Maternal Depression Screening
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS117: Childhood Immunization Status
CMS122: Diabetes: Hemoglobin A1c Poor Control
CMS123: Diabetes: Foot Exam
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS126: Use of Appropriate Medications for Asthma
CMS127: Pneumonia Vaccination Status for Older Adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130: Colorectal Cancer Screening
CMS131: Diabetes: Eye Exam
CMS132: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures
CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS134: Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS148: Hemoglobin A1c Test for Pediatric Patients
CMS149: Dementia: Cognitive Assessment
CMS153: Chlamydia Screening for Women
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156: Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS158: Pregnant women that had HBsAg testing
CMS159: Depression Remission at Twelve Months
CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS163: Diabetes: Low Density Lipoprotein (LDL) Management
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain
CMS167: Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
CMS169: Bipolar Disorder and Major Depression: Appraisal for alcohol or chemical substance use
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control>

Pulse Complete EHR 4.2.08 CHPL ID: 140162R00  |  Certified: 06.27.2014

Certification Criteria

  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(2) – Automated measure calculation
  • 170.314(g)(4) – Quality management system
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance
  • 170.314(g)(3) – Safety-enhanced design

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS56: Functional Status Assessment for Hip Replacement
CMS61: Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed
CMS62: HIV/AIDS: Medical Visit
CMS65: Hypertension: Improvement in Blood Pressure
CMS66: Functional Status Assessment for Knee Replacement>
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS75: Children Who Have Dental Decay or Cavities
CMS77: HIV/AIDS: RNA control for Patients with HIV
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS122: Diabetes: Hemoglobin A1c Poor Control
CMS123: Diabetes: Foot Exam
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS126: Use of Appropriate Medications for Asthma
CMS127: Pneumonia Vaccination Status for Older Adults
CMS128: Anti-depressant Medication Management
CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS130: Colorectal Cancer Screening
CMS131: Diabetes: Eye Exam
CMS134: Diabetes: Urine Protein Screening
CMS135: Heart Failure (HF): AngiotensinConverting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS143: Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS144: Heart Failure (HF): BetaBlocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)
CMS146: Appropriate Testing for Children with Pharyngitis
CMS147: Preventive Care and Screening: Influenza Immunization
CMS148: Hemoglobin A1c Test for Pediatric Patients
CMS153: Chlamydia Screening for Women
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
CMS156: Use of High-Risk Medications in the Elderly
CMS157: Oncology: Medical and Radiation – Pain Intensity Quantified
CMS158: Pregnant women that had HBsAg testing
CMS163: Diabetes: Low Density Lipoprotein (LDL) Management
CMS164: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain
CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS182: Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control>

Pulse Complete EHR 4.2 CHPL ID: 140035R00  |  Certified: 09.07.2013

Certification Criteria

  • 170.314(a)(1) – Computerized provider order entry
  • 170.314(a)(3) – Demographics
  • 170.314(a)(5) – Problem list
  • 170.314(a)(7) – Medication allergy list
  • 170.314(a)(9) – Electronic notes
  • 170.314(a)(11) – Smoking status
  • 170.314(a)(13) – Family health history
  • 170.314(a)(15) – Patient-specific education resources
  • 170.314(b)(2) – Transitions of care – create and transmit transition of care/referral summaries
  • 170.314(b)(4) – Clinical information reconciliation
  • 170.314(b)(7) – Data portability
  • 170.314(c)(2) – Clinical quality measures – import and calculate
  • 170.314(d)(1) – Authentication, access, control, and authorization
  • 170.314(d)(3) – Audit report(s)
  • 170.314(d)(5) – Automatic log-off
  • 170.314(d)(7) – End-user device encryption
  • 170.314(d)(9) – Optional—accounting of disclosures
  • 170.314(e)(2) – Ambulatory setting only -clinical summary
  • 170.314(f)(2) – Transmission to immunization registries
  • 170.314(g)(3) – Safety-enhanced design
  • 170.314(a)(2) – Drug-drug, drug-allergy interactions checks
  • 170.314(a)(4) – Vital signs, body mass index, and growth Charts
  • 170.314(a)(6) – Medication list
  • 170.314(a)(8) – Clinical decision support
  • 170.314(a)(10) – Drug formulary checks
  • 170.314(a)(12) – Image results
  • 170.314(a)(14) – Patient list creation
  • 170.314(b)(1) – Transitions of care – receive, display and incorporate transition of care/referral summaries
  • 170.314(b)(3) – Electronic prescribing
  • 170.314(b)(5)(A) – Incorporate laboratory tests and values/results
  • 170.314(c)(1) – Clinical quality measures – capture and export
  • 170.314(c)(3) – Clinical quality measures – electronic submission
  • 170.314(d)(2) – Auditable events and tamper-resistance
  • 170.314(d)(4) – Amendments
  • 170.314(d)(6) – Emergency access
  • 170.314(d)(8) – Integrity
  • 170.314(e)(1) – View, download, and transmit to a 3rd party with edge protocol testing
  • 170.314(e)(3) – Ambulatory setting only – secure messaging
  • 170.314(f)(1) – Immunization information
  • 170.314(f)(3) – Transmission to public health agencies – syndromic surveillance

Clinical Quality Measures

CMS2: Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS50: Closing the Referral Loop: Receipt of Specialist Report
CMS56: Functional Status Assessment for Hip Replacement
CMS66: Functional Status Assessment for Knee Replacement>
CMS68: Documentation of Current Medications in the Medical Record
CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS90: Functional Status Assessment for Complex Chronic Conditions
CMS124: Cervical Cancer Screening
CMS125: Breast Cancer Screening
CMS127: Pneumonia Vaccination Status for Older Adults
CMS130: Colorectal Cancer Screening
CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS139: Falls: Screening for Future Fall Risk
CMS147: Preventive Care and Screening: Influenza Immunization
CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
CMS156: Use of High-Risk Medications in the Elderly
CMS165: Controlling High Blood Pressure
CMS166: Use of Imaging Studies for Low Back Pain

Disclosure Statements (All Versions)

Pulse Complete EHR may require one-time costs to establish interfaces for reporting to immunization registries, cancer registries, specialty registries, public health agencies and lab and radiology interfaces. Additional monthly interface support costs may be incurred upon client request.

Pulse Complete EHR is certified to data export criteria and can create a set of export summaries in real time. Though the user can create a set of export summaries in real time, this type of mass export is recommended as best practice to be scheduled during off-peak hours to reduce performance stress on the system.

Pulse Complete EHR may require annual fees associated with obtaining/maintaining certificates for communication through the HISP network.

Pulse Complete EHR may require monthly costs to support online patient services through the Pulse Patient Portal.

Pulse Complete EHR may require one-time costs to establish eprescribing functionality as well as monthly fees.

Additional Software

First DataBank, Medicomp Medcin Clinical Knowledge Engine.

Highlights

  • Customizable Clinical Management (CMD) Dashboard

  • Flexible Workflow Management Tasking

  • Customizable Electronic Charting

  • Automated Care and Order Management

  • Point-of-Care Electronic Charting with E&M Code Check

  • An ICD-10 Ready Clinical Knowledge Engine with Decision Support

  • Integrated Document, Fax and Transcription Management

  • E-Prescribing with Real-Time Access to Interactions/Allergies, Formularies, Alternatives and Prior Medication History

  • Point-of-Care Templates/Form Designer

  • Meaningful Use Reporter

 

The Pulse Complete EHR, version 5.0.14, is licensed on a per provider basis with monthly recurring fees and includes all components to meet Meaningful Use.

Learn more or schedule a live product demo by contacting Pulse at 800.444.0882.

 

 

Complete our Needs Assessment Form or schedule a live product demo by contacting a Pulse representative at 800-444-0882 x3.

Connect with Pulse

To keep up with our latest updates and to support our goals please visit us on our facebook & Twitter pages.